The Priority Review

Tag

Sanofi

2 stories

  1. Clinical trials

    Sanofi posts results of Phase 3 itepekimab trial in COPD

    The Phase 3 study, NCT04701983 (AERIFY-1), enrolled 1127 participants and completed primary data collection on April 11, 2025. Results were first posted on ClinicalTrials.gov on October 15, 2026.

  2. Clinical trials

    Sanofi posts results of Phase 3 Itepekimab trial in COPD

    The study, NCT04751487 (AERIFY-2), enrolled 1234 participants and completed in April 2025. It evaluated itepekimab versus placebo on exacerbation rates, pulmonary function, and safety in moderate-to-severe COPD patients.